期刊
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
卷 35, 期 4, 页码 450-455出版社
SPRINGER
DOI: 10.1007/s11239-012-0859-7
关键词
Transcatheter aortic valve implantation; Atrial fibrillation; Antithrombotic; Stroke
Atrial fibrillation (AF) is a common co-morbidity among patients undergoing Transcatheter Aortic Valve Implantation (TAVI). Only recently have the clinical outcomes of patients with chronic or new-onset AF after TAVI been reported. The absence of clinical trials focusing on this cohort of patients has resulted in the lack of evidence based clinical guidelines. We aim to review and discuss the current literature on AF in TAVI, its clinical implications and future perspectives.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据